CEACAM5 and neoplasm: found that the use of plasmid DNA vaccine carrying carcinoembryonic antigen (CEA) can stimulate tumour‐bearing mice to produce CEA‐specific T cells and antibody responses, and the level of anti‐CEA‐specific IgG antibody in the serum of tumour‐bearing mice also increases.